James Shin
Stock Analyst at Deutsche Bank
(2.77)
# 1,989
Out of 5,067 analysts
23
Total ratings
60%
Success rate
22.11%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $100.40 | +10.56% | 3 | Nov 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $1,070.16 | -15.90% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $10.60 | -5.66% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $125.27 | -4.21% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $334.30 | -8.76% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $106.24 | -43.52% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $47.76 | -5.78% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $27.15 | +120.99% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $229.51 | -34.64% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $761.45 | +5.06% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.24 | +706.45% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $0.88 | +1,271.43% | 1 | Nov 9, 2023 |
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $100.40
Upside: +10.56%
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $1,070.16
Upside: -15.90%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $10.60
Upside: -5.66%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $125.27
Upside: -4.21%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $334.30
Upside: -8.76%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $106.24
Upside: -43.52%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $47.76
Upside: -5.78%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $27.15
Upside: +120.99%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $229.51
Upside: -34.64%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $761.45
Upside: +5.06%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.24
Upside: +706.45%
Nov 9, 2023
Initiates: Buy
Price Target: $12
Current: $0.88
Upside: +1,271.43%